The DOI matches its Crossref record; 295 of the 295 references it cites were found in a registry or an index.
Oxidized LDL: Diversity, Patterns of Recognition, and Pathophysiology
Open accessAbstract
Oxidative modification of LDL is known to elicit an array of pro-atherogenic responses, but it is generally underappreciated that oxidized LDL (OxLDL) exists in multiple forms, characterized by different degrees of oxidation and different mixtures of bioactive components. The variable effects of OxLDL reported in the literature can be attributed in large part to the heterogeneous nature of the preparations employed. In this review, we first describe the various subclasses and molecular composition of OxLDL, including the variety of minimally modified LDL preparations. We then describe multiple receptors that recognize various species of OxLDL and discuss the mechanisms responsible for the recognition by specific receptors. Furthermore, we discuss the contentious issues such as the nature of OxLDL in vivo and the physiological oxidizing agents, whether oxidation of LDL is a prerequisite for atherogenesis, whether OxLDL is the major source of lipids in foam cells, whether in some cases it actually induces cholesterol depletion, and finally the Janus-like nature of OxLDL in having both pro- and anti-inflammatory effects. Lastly, we extend our review to discuss the role of LDL oxidation in diseases other than atherosclerosis, including diabetes mellitus, and several autoimmune diseases, such as lupus erythematosus, anti-phospholipid syndrome, and rheumatoid arthritis.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
1 retracted
Kincer, J. F., Uittenbogaard, A., Dressman, J. L., Guerin, T. M., Febbraio, M., Guo, L., & Smart, E. J. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m202465200 · Cited by 54
RetractedAtherosclerosis--an inflammatory disease
Ross, R. (1999) · New England Journal of Medicine · doi:10.1056/nejm199901143400207 · Cited by 21,725
Inflammation in atherosclerosis
Libby, P. (2002) · Nature · doi:10.1038/nature01323 · Cited by 8,315
Epstein, F. H., Steinberg, D., Parthasarathy, S., Carew, T. E., Khoo, J. C., & Witztum, J. L. (1989) · New England Journal of Medicine · doi:10.1056/nejm198904063201407 · Cited by 6,427
A Receptor-Mediated Pathway for Cholesterol Homeostasis
Brown, M. S., & Goldstein, J. L. (1986) · Science · doi:10.1126/science.3513311 · Cited by 5,703
Inflammation in Atherosclerosis
Libby, P. (2012) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/atvbaha.108.179705 · Cited by 3,736
Role of oxidized low density lipoprotein in atherogenesis.
Witztum, J. L., & Steinberg, D. (1991) · Journal of Clinical Investigation · doi:10.1172/jci115499 · Cited by 2,675
Role of Oxidative Modifications in Atherosclerosis
Stocker, R., & Keaney, J. F. (2004) · Physiological Reviews · doi:10.1152/physrev.00047.2003 · Cited by 2,624
Goldstein, J. L., Ho, Y. K., Basu, S. K., & Brown, M. S. (1979) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.76.1.333 · Cited by 2,448
The plasma lecithin:cholesterol acyltransferase reaction
Glomset, J. A. (1968) · Journal of Lipid Research · doi:10.1016/s0022-2275(20)43114-1 · Cited by 2,405
LIPOPROTEIN METABOLISM IN THE MACROPHAGE: Implications for Cholesterol Deposition in Atherosclerosis
Brown, M. S., & Goldstein, J. L. (1983) · Annual Review of Biochemistry · doi:10.1146/annurev.bi.52.070183.001255 · Cited by 2,300
Halliwell, B., & Whiteman, M. (2004) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0705776 · Cited by 2,238
Book ReviewAmbulatory Pediatric Care
Steinberg, J. B. (1989) · New England Journal of Medicine · doi:10.1056/nejm198901053200122 · Cited by 2,108
Identification of Scavenger Receptor SR-BI as a High Density Lipoprotein Receptor
Acton, S., Rigotti, A., Landschulz, K. T., Xu, S., Hobbs, H. H., & Krieger, M. (1996) · Science · doi:10.1126/science.271.5248.518 · Cited by 2,026
Oxidized LDL Regulates Macrophage Gene Expression through Ligand Activation of PPARγ
Nagy, L., Tontonoz, P., Alvarez, J. G. A., Chen, H., & Evans, R. M. (1998) · Cell · doi:10.1016/s0092-8674(00)81574-3 · Cited by 1,860
Loss of Caveolae, Vascular Dysfunction, and Pulmonary Defects in Caveolin-1 Gene-Disrupted Mice
Drab, M., Verkade, P., Elger, M., Kasper, M., Lohn, M., Lauterbach, B., Menne, J., Lindschau, C., Mende, F., Luft, F. C., et al. (2001) · Science · doi:10.1126/science.1062688 · Cited by 1,552
An endothelial receptor for oxidized low-density lipoprotein
Sawamura, T., Kume, N., Aoyama, T., Moriwaki, H., Hoshikawa, H., Aiba, Y., Tanaka, T., Miwa, S., Katsura, Y., Kita, T., et al. (1997) · Nature · doi:10.1038/386073a0 · Cited by 1,385
Autoantibody against oxidised LDL and progression of carotid atherosclerosis
Salonen, J. T., Korpela, H., Salonen, R., Nyyssonen, K., Yla-Herttuala, S., Yamamoto, R., Butler, S., Palinski, W., & Witztum, J. L. (1992) · The Lancet · doi:10.1016/0140-6736(92)90926-t · Cited by 1,316
Stary, H. C., Chandler, A. B., Glagov, S., Guyton, J. R., Insull, W., Rosenfeld, M. E., Schaffer, S. A., Schwartz, C. J., Wagner, W. D., & Wissler, R. W. (1994) · Circulation · doi:10.1161/01.cir.89.5.2462 · Cited by 1,312
CD36 is a receptor for oxidized low density lipoprotein
Endemann, G., Stanton, L. W., Madden, K. S., Bryant, C. M., White, R. T., & Protter, A. A. (1993) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(19)50272-1 · Cited by 1,281
Ravetch, J. V., & Kinet, J. P. (1991) · Annual Review of Immunology · doi:10.1146/annurev.iy.09.040191.002325 · Cited by 1,229
A role for macrophage scavenger receptors in atherosclerosis and susceptibility to infection
Suzuki, H., Kurihara, Y., Takeya, M., Kamada, N., Kataoka, M., Jishage, K., Ueda, O., Sakaguchi, H., Higashi, T., Suzuki, T., et al. (1997) · Nature · doi:10.1038/386292a0 · Cited by 1,224
Krieger, M., & Krieger, J. (1994) · Annual Review of Biochemistry · doi:10.1146/annurev.bi.63.070194.003125 · Cited by 1,160
Methotrexate and mortality in patients with rheumatoid arthritis: a prospective study
Choi, H. K., Hernán, M. A., Seeger, J. D., Robins, J. M., & Wolfe, F. (2002) · The Lancet · doi:10.1016/s0140-6736(02)08213-2 · Cited by 1,127
Febbraio, M., Podrez, E. A., Smith, J. D., Hajjar, D. P., Hazen, S. L., Hoff, H. F., Sharma, K., & Silverstein, R. L. (2000) · Journal of Clinical Investigation · doi:10.1172/jci9259 · Cited by 1,044
Type I macrophage scavenger receptor contains α-helical and collagen-like coiled coils
Kodama, T., Freeman, M., Rohrer, L., Zabrecky, J., Matsudaira, P., & Krieger, M. (1990) · Nature · doi:10.1038/343531a0 · Cited by 1,041
Kunjathoor, V. V., Febbraio, M., Podrez, E. A., Moore, K. J., Andersson, L., Koehn, S., Rhee, J. S., Silverstein, R., Hoff, H. F., & Freeman, M. W. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m209649200 · Cited by 1,028
Henriksen, T., Mahoney, E. M., & Steinberg, D. (1981) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.78.10.6499 · Cited by 1,021
Basu, S. K., Goldstein, J. L., Anderson, G. W., & Brown, M. S. (1976) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.73.9.3178 · Cited by 1,021
Minimally modified low density lipoprotein stimulates monocyte endothelial interactions.
Berliner, J. A., Territo, M. C., Sevanian, A., Ramin, S., Kim, J. A., Bamshad, B., Esterson, M., & Fogelman, A. M. (1990) · Journal of Clinical Investigation · doi:10.1172/jci114562 · Cited by 925
Oxysterols and atherosclerosis
Brown, A. J., & Jessup, W. (1999) · Atherosclerosis · doi:10.1016/s0021-9150(98)00196-8 · Cited by 919
Rigotti, A., Trigatti, B. L., Penman, M., Rayburn, H., Herz, J., & Krieger, M. (1997) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.94.23.12610 · Cited by 860
Interleukin-4-dependent production of PPAR-γ ligands in macrophages by 12/15-lipoxygenase
Huang, J. T., Welch, J. S., Ricote, M., Binder, C. J., Willson, T. M., Kelly, C., Witztum, J. L., Funk, C. D., Conrad, D., & Glass, C. K. (1999) · Nature · doi:10.1038/22572 · Cited by 855
Expression cloning of SR-BI, a CD36-related class B scavenger receptor.
Acton, S. L., Scherer, P. E., Lodish, H. F., & Krieger, M. (1994) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(17)31921-x · Cited by 821
Isoprostanes: markers and mediators of oxidative stress
Montuschi, P., Barnes, P. J., & Roberts, L. J. (2004) · The FASEB Journal · doi:10.1096/fj.04-2330rev · Cited by 747
Stary, H. C., Chandler, A. B., Glagov, S., Guyton, J. R., Insull, W., Rosenfeld, M. E., Schaffer, S. A., Schwartz, C. J., Wagner, W. D., & Wissler, R. W. (1994) · Arteriosclerosis and Thrombosis: A Journal of Vascular Biology · doi:10.1161/01.atv.14.5.840 · Cited by 742
Navab, M., Hama, S. Y., Anantharamaiah, G. M., Hassan, K., Hough, G. P., Watson, A. D., Reddy, S. T., Sevanian, A., Fonarow, G. C., & Fogelman, A. M. (2000) · Journal of Lipid Research · doi:10.1016/s0022-2275(20)33462-3 · Cited by 668
Quinn, M. T., Parthasarathy, S., & Steinberg, D. (1988) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.85.8.2805 · Cited by 650
Innate and acquired immunity in atherogenesis
Binder, C. J., Chang, M.-K., Shaw, P. X., Miller, Y. I., Hartvigsen, K., Dewan, A., & Witztum, J. L. (2002) · Nature Medicine · doi:10.1038/nm1102-1218 · Cited by 642
Steinbrecher, U. P. (1987) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)61395-x · Cited by 615
Bucci, M., Gratton, J.-P., Rudic, R. D., Acevedo, L., Roviezzo, F., Cirino, G., & Sessa, W. C. (2000) · Nature Medicine · doi:10.1038/82176 · Cited by 572
Scavenger Receptors in Atherosclerosis: Beyond Lipid Uptake
Moore, K. J., & Freeman, M. W. (2006) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/01.atv.0000229218.97976.43 · Cited by 562
Hörkkö, S., Bird, D. A., Miller, E., Itabe, H., Leitinger, N., Subbanagounder, G., Berliner, J. A., Friedman, P., Dennis, E. A., Curtiss, L. K., et al. (1999) · Journal of Clinical Investigation · doi:10.1172/jci4533 · Cited by 559
Palinski, W., Hörkkö, S., Miller, E., Steinbrecher, U. P., Powell, H. C., Curtiss, L. K., & Witztum, J. L. (1996) · Journal of Clinical Investigation · doi:10.1172/jci118853 · Cited by 559
The Class B Scavenger Receptors SR-BI and CD36 Are Receptors for Anionic Phospholipids
Rigotti, A., Acton, S. L., & Krieger, M. (1995) · Journal of Biological Chemistry · doi:10.1074/jbc.270.27.16221 · Cited by 557
Landschulz, K. T., Pathak, R. K., Rigotti, A., Krieger, M., & Hobbs, H. H. (1996) · Journal of Clinical Investigation · doi:10.1172/jci118883 · Cited by 536
Elomaa, O., Kangas, M., Sahlberg, C., Tuukkanen, J., Sormunen, R., Liakka, A., Thesleff, I., Kraal, G., & Tryggvason, K. (1995) · Cell · doi:10.1016/0092-8674(95)90514-6 · Cited by 514
Cominacini, L., Pasini, A. F., Garbin, U., Davoli, A., Tosetti, M. L., Campagnola, M., Rigoni, A., Pastorino, A. M., Lo Cascio, V., & Sawamura, T. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.275.17.12633 · Cited by 510
Rosenfeld, M. E., Palinski, W., Ylä-Herttuala, S., Butler, S., & Witztum, J. L. (1990) · Arteriosclerosis: An Official Journal of the American Heart Association, Inc. · doi:10.1161/01.atv.10.3.336 · Cited by 474
Enhanced macrophage degradation of biologically modified low density lipoprotein.
Henriksen, T., Mahoney, E. M., & Steinberg, D. (1983) · Arteriosclerosis: An Official Journal of the American Heart Association, Inc. · doi:10.1161/01.atv.3.2.149 · Cited by 473
Steinbrecher, U. P., Witztum, J. L., Parthasarathy, S., & Steinberg, D. (1987) · Arteriosclerosis: An Official Journal of the American Heart Association, Inc. · doi:10.1161/01.atv.7.2.135 · Cited by 468
Coiled-coil fibrous domains mediate ligand binding by macrophage scavenger receptor type II
Rohrer, L., Freeman, M., Kodama, T., Penman, M., & Krieger, M. (1990) · Nature · doi:10.1038/343570a0 · Cited by 457
Podrez, E. A., Febbraio, M., Sheibani, N., Schmitt, D., Silverstein, R. L., Hajjar, D. P., Cohen, P. A., Frazier, W. A., Hoff, H. F., & Hazen, S. L. (2000) · Journal of Clinical Investigation · doi:10.1172/jci8574 · Cited by 455
Podrez, E. A., Poliakov, E., Shen, Z., Zhang, R., Deng, Y., Sun, M., Finton, P. J., Shan, L., Gugiu, B., Fox, P. L., et al. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m203318200 · Cited by 449
Kataoka, H., Kume, N., Miyamoto, S., Minami, M., Moriwaki, H., Murase, T., Sawamura, T., Masaki, T., Hashimoto, N., & Kita, T. (1999) · Circulation · doi:10.1161/01.cir.99.24.3110 · Cited by 443
Deletion of LOX-1 Reduces Atherogenesis in LDLR Knockout Mice Fed High Cholesterol Diet
Mehta, J. L., Sanada, N., Hu, C. P., Chen, J., Dandapat, A., Sugawara, F., Satoh, H., Inoue, K., Kawase, Y., Jishage, K.-I., et al. (2007) · Circulation Research · doi:10.1161/circresaha.107.149724 · Cited by 443
The Oxidative Modification Hypothesis of Atherosclerosis Does It Hold for Humans?
Witztum, J. (2001) · Trends in Cardiovascular Medicine · doi:10.1016/s1050-1738(01)00111-6 · Cited by 440
Bae, Y. S., Lee, J. H., Choi, S. H., Kim, S., Almazan, F., Witztum, J. L., & Miller, Y. I. (2009) · Circulation Research · doi:10.1161/circresaha.108.181040 · Cited by 427
Primary Endothelial Dysfunction: Atherosclerosis
Shimokawa, H. (1999) · Journal of Molecular and Cellular Cardiology · doi:10.1006/jmcc.1998.0841 · Cited by 416
Antioxidant Vitamin Supplements and Cardiovascular Disease
Kris-Etherton, P. M., Lichtenstein, A. H., Howard, B. V., Steinberg, D., & Witztum, J. L. (2004) · Circulation · doi:10.1161/01.cir.0000137822.39831.f1 · Cited by 408
Park, Y. M., Febbraio, M., & Silverstein, R. L. (2008) · Journal of Clinical Investigation · doi:10.1172/jci35535 · Cited by 406
Siess, W., Zangl, K. J., Essler, M., Bauer, M., Brandl, R., Corrinth, C., Bittman, R., Tigyi, G., & Aepfelbacher, M. (1999) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.96.12.6931 · Cited by 404
Miller, Y. I., Viriyakosol, S., Binder, C. J., Feramisco, J. R., Kirkland, T. N., & Witztum, J. L. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m209634200 · Cited by 399
CD36 and macrophages in atherosclerosis
COLLOTTEIXEIRA, S., MARTIN, J., MCDERMOTTROE, C., POSTON, R., & MCGREGOR, J. (2007) · Cardiovascular Research · doi:10.1016/j.cardiores.2007.03.010 · Cited by 389
Moore, K. J., Kunjathoor, V. V., Koehn, S. L., Manning, J. J., Tseng, A. A., Silver, J. M., McKee, M., & Freeman, M. W. (2005) · Journal of Clinical Investigation · doi:10.1172/jci24061 · Cited by 378
Chen, M., Masaki, T., & Sawamura, T. (2002) · Pharmacology & Therapeutics · doi:10.1016/s0163-7258(02)00236-x · Cited by 375
Blair, A., Shaul, P. W., Yuhanna, I. S., Conrad, P. A., & Smart, E. J. (1999) · Journal of Biological Chemistry · doi:10.1074/jbc.274.45.32512 · Cited by 360
Regulation and biological activities of the autotaxin–LPA axis
van Meeteren, L. A., & Moolenaar, W. H. (2007) · Progress in Lipid Research · doi:10.1016/j.plipres.2007.02.001 · Cited by 353
Modified forms of low density lipoprotein and atherosclerosis
Aviram, M. (1993) · Atherosclerosis · doi:10.1016/0021-9150(93)90217-i · Cited by 345
Schissel, S. L., Tweedie-Hardman, J., Rapp, J. H., Graham, G., Williams, K. J., & Tabas, I. (1996) · Journal of Clinical Investigation · doi:10.1172/jci118934 · Cited by 341
Biochemistry and cell biology of mammalian scavenger receptors
Murphy, J. E., Tedbury, P. R., Homer-Vanniasinkam, S., Walker, J. H., & Ponnambalam, S. (2005) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2005.03.036 · Cited by 333
Scavenger Receptors, Oxidized LDL, and Atherosclerosis
BOULLIER, A., BIRD, D. A., CHANG, M., DENNIS, E. A., FRIEDMAN, P., GILLOTTE‐TAYLOR, K., HÖRKKÖ, S., PALINSKI, W., QUEHENBERGER, O., SHAW, P., et al. (2001) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.2001.tb03943.x · Cited by 330
Cracowski, J.-L., Durand, T., & Bessard, G. (2002) · Trends in Pharmacological Sciences · doi:10.1016/s0165-6147(02)02053-9 · Cited by 330
Macrophage scavenger receptors and host-derived ligands
Plüddemann, A., Neyen, C., & Gordon, S. (2007) · Methods · doi:10.1016/j.ymeth.2007.06.004 · Cited by 327
Toloza, S. M. A., Uribe, A. G., McGwin, G., Alarcón, G. S., Fessler, B. J., Bastian, H. M., Vilá, L. M., Wu, R., Shoenfeld, Y., Roseman, J. M., et al. (2004) · Arthritis & Rheumatism · doi:10.1002/art.20622 · Cited by 319
Arai, T., Wang, N., Bezouevski, M., Welch, C., & Tall, A. R. (1999) · Journal of Biological Chemistry · doi:10.1074/jbc.274.4.2366 · Cited by 312
Role of Lysophosphatidylcholine (LPC) in Atherosclerosis
Matsumoto, T., Kobayashi, T., & Kamata, K. (2007) · Current Medicinal Chemistry · doi:10.2174/092986707782793899 · Cited by 312
Uittenbogaard, A., Shaul, P. W., Yuhanna, I. S., Blair, A., & Smart, E. J. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.275.15.11278 · Cited by 310
Freeman, M., Ashkenas, J., Rees, D. J., Kingsley, D. M., Copeland, N. G., Jenkins, N. A., & Krieger, M. (1990) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.87.22.8810 · Cited by 309
Varban, M. L., Rinninger, F., Wang, N., Fairchild-Huntress, V., Dunmore, J. H., Fang, Q., Gosselin, M. L., Dixon, K. L., Deeds, J. D., Acton, S. L., et al. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.8.4619 · Cited by 303
Induction of heme oxygenase-1 inhibits the monocyte transmigration induced by mildly oxidized LDL.
Ishikawa, K., Navab, M., Leitinger, N., Fogelman, A. M., & Lusis, A. J. (1997) · Journal of Clinical Investigation · doi:10.1172/jci119634 · Cited by 289
HYPOXIC-REPERFUSION INJURY IN THE INFLAMED HUMAN JOINT
Blake, D. R., Unsworth, J., Outhwaite, J. M., Morris, C. J., Merry, P., Kidd, B. L., Ballard, R., Gray, L., & Lunec, J. (1989) · The Lancet · doi:10.1016/s0140-6736(89)91305-6 · Cited by 286
Sensitive detection of oxidatively modified low density lipoprotein using a monoclonal antibody.
Itabe, H., Yamamoto, H., Imanaka, T., Shimamura, K., Uchiyama, H., Kimura, J., Sanaka, T., Hata, Y., & Takano, T. (1996) · Journal of Lipid Research · doi:10.1016/s0022-2275(20)37634-3 · Cited by 277
Karvonen, J., Päivänsalo, M., Kesäniemi, Y. A., & Hörkkö, S. (2003) · Circulation · doi:10.1161/01.cir.0000092891.55157.a7 · Cited by 274
Mechanisms of oxidative damage of low density lipoprotein in human atherosclerosis
Heinecke, J. W. (1997) · Current Opinion in Lipidology · doi:10.1097/00041433-199710000-00005 · Cited by 273
Nicholson, A. C., Frieda, S., Pearce, A., & Silverstein, R. L. (1995) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/01.atv.15.2.269 · Cited by 268
Autoimmunity and oxidatively modified autoantigens
Kurien, B. T., & Scofield, R. H. (2008) · Autoimmunity Reviews · doi:10.1016/j.autrev.2008.04.019 · Cited by 268
Zhang, Y. (2005) · Journal of Clinical Investigation · doi:10.1172/jci25327 · Cited by 267
Burkitt, M. J. (2001) · Archives of Biochemistry and Biophysics · doi:10.1006/abbi.2001.2509 · Cited by 266
Manning-Tobin, J. J., Moore, K. J., Seimon, T. A., Bell, S. A., Sharuk, M., Alvarez-Leite, J. I., de Winther, M. P. J., Tabas, I., & Freeman, M. W. (2009) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/atvbaha.108.176644 · Cited by 266
Malondialdehyde-modified low density lipoproteins in patients with atherosclerotic disease.
Holvoet, P., Perez, G., Zhao, Z., Brouwers, E., Bernar, H., & Collen, D. (1995) · Journal of Clinical Investigation · doi:10.1172/jci117963 · Cited by 262
Structure and Localization of the Human Gene Encoding SR-BI/CLA-1
Cao, G., Garcia, C. K., Wyne, K. L., Schultz, R. A., Parker, K. L., & Hobbs, H. H. (1997) · Journal of Biological Chemistry · doi:10.1074/jbc.272.52.33068 · Cited by 261
Purification and characterization of a bovine acetyl low density lipoprotein receptor.
Kodama, T., Reddy, P., Kishimoto, C., & Krieger, M. (1988) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.85.23.9238 · Cited by 259
Endothelial function, inflammation, and prognosis in cardiovascular disease
Gonzalez, M. A., & Selwyn, A. P. (2003) · The American Journal of Medicine · doi:10.1016/j.amjmed.2003.09.016 · Cited by 258
Pearson, A., Lux, A., & Krieger, M. (1995) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.92.9.4056 · Cited by 249
Macrophage Scavenger Receptor Class A: A Multifunctional Receptor in Atherosclerosis
de Winther, M. P. J., van Dijk, K. W., Havekes, L. M., & Hofker, M. H. (2000) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/01.atv.20.2.290 · Cited by 249
Frostegård, J., Svenungsson, E., Wu, R., Gunnarsson, I., Lundberg, I. E., Klareskog, L., Hörkkö, S., & Witztum, J. L. (2005) · Arthritis & Rheumatism · doi:10.1002/art.20780 · Cited by 243
Oxidation of LDL and its clinical implication
Matsuura, E., Hughes, G. R. V., & Khamashta, M. A. (2008) · Autoimmunity Reviews · doi:10.1016/j.autrev.2008.04.018 · Cited by 238 · cited 5×
“In contrast to SLE, while RA patients showed higher anti-OxLDL=b2GPI antibody levels than the controls, this difference was not statistically significant (181).”
InfluentialHarats, D., Shaish, A., George, J., Mulkins, M., Kurihara, H., Levkovitz, H., & Sigal, E. (2000) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/01.atv.20.9.2100 · Cited by 238
Cyrus, T., Praticò, D., Zhao, L., Witztum, J. L., Rader, D. J., Rokach, J., FitzGerald, G. A., & Funk, C. D. (2001) · Circulation · doi:10.1161/01.cir.103.18.2277 · Cited by 232
Okajima, F. (2002) · Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids · doi:10.1016/s1388-1981(02)00147-6 · Cited by 231
Lipoprotein Accumulation in Macrophages via Toll-Like Receptor-4–Dependent Fluid Phase Uptake
Choi, S.-H., Harkewicz, R., Lee, J. H., Boullier, A., Almazan, F., Li, A. C., Witztum, J. L., Bae, Y. S., & Miller, Y. I. (2009) · Circulation Research · doi:10.1161/circresaha.108.192880 · Cited by 230
Genetic Ablation of Caveolin-1 Confers Protection Against Atherosclerosis
Frank, P. G., Lee, H., Park, D. S., Tandon, N. N., Scherer, P. E., & Lisanti, M. P. (2004) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/01.atv.0000101182.89118.e5 · Cited by 223
The Membrane-type Collectin CL-P1 Is a Scavenger Receptor on Vascular Endothelial Cells
Ohtani, K., Suzuki, Y., Eda, S., Kawai, T., Kase, T., Keshi, H., Sakai, Y., Fukuoh, A., Sakamoto, T., Itabe, H., et al. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m103942200 · Cited by 216
Pitas, R. E., Boyles, J., Mahley, R. W., & Bissell, D. M. (1985) · The Journal of cell biology · doi:10.1083/jcb.100.1.103 · Cited by 215
Haberland, M. E., Olch, C. L., & Folgelman, A. M. (1984) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)90863-x · Cited by 211
Receptors for oxidized low density lipoprotein
Steinbrecher, U. (1999) · Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids · doi:10.1016/s0005-2760(98)00127-1 · Cited by 211
Freeman, M., Ekkel, Y., Rohrer, L., Penman, M., Freedman, N. J., Chisolm, G. M., & Krieger, M. (1991) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.88.11.4931 · Cited by 210
Kuchibhotla, S., Vanegas, D., Kennedy, D. J., Guy, E., Nimako, G., Morton, R. E., & Febbraio, M. (2008) · Cardiovascular Research · doi:10.1093/cvr/cvm093 · Cited by 209
Watson, A. D., Subbanagounder, G., Welsbie, D. S., Faull, K. F., Navab, M., Jung, M. E., Fogelman, A. M., & Berliner, J. A. (1999) · Journal of Biological Chemistry · doi:10.1074/jbc.274.35.24787 · Cited by 206
Hughes, D. A., Fraser, I. P., & Gordon, S. (1995) · European Journal of Immunology · doi:10.1002/eji.1830250224 · Cited by 204
Huo, Y., Zhao, L., Hyman, M. C., Shashkin, P., Harry, B. L., Burcin, T., Forlow, S. B., Stark, M. A., Smith, D. F., Clarke, S., et al. (2004) · Circulation · doi:10.1161/01.cir.0000143628.37680.f6 · Cited by 196
A macrophage Fc receptor for IgG is also a receptor for oxidized low density lipoprotein.
Stanton, L. W., White, R. T., Bryant, C. M., Protter, A. A., & Endemann, G. (1992) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)41692-4 · Cited by 192
Boullier, A., Gillotte, K. L., Hörkkö, S., Green, S. R., Friedman, P., Dennis, E. A., Witztum, J. L., Steinberg, D., & Quehenberger, O. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.275.13.9163 · Cited by 190
New insights on oxidative stress in the artery wall
STOCKER, R., & KEANEY, J. F. (2005) · Journal of Thrombosis and Haemostasis · doi:10.1111/j.1538-7836.2005.01370.x · Cited by 188
Ligand Specificity of LOX-1, a Novel Endothelial Receptor for Oxidized Low Density Lipoprotein
Moriwaki, H., Kume, N., Sawamura, T., Aoyama, T., Hoshikawa, H., Ochi, H., Nishi, E., Masaki, T., & Kita, T. (1998) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/01.atv.18.10.1541 · Cited by 188
Kobayashi, K., Kishi, M., Atsumi, T., Bertolaccini, M. L., Makino, H., Sakairi, N., Yamamoto, I., Yasuda, T., Khamashta, M. A., Hughes, G. R. V., et al. (2003) · Journal of Lipid Research · doi:10.1194/jlr.m200329-jlr200 · Cited by 188
Impact of Plasma Oxidized Low-Density Lipoprotein Removal on Atherosclerosis
Ishigaki, Y., Katagiri, H., Gao, J., Yamada, T., Imai, J., Uno, K., Hasegawa, Y., Kaneko, K., Ogihara, T., Ishihara, H., et al. (2008) · Circulation · doi:10.1161/circulationaha.107.745174 · Cited by 187
Subbanagounder, G., Wong, J. W., Lee, H., Faull, K. F., Miller, E., Witztum, J. L., & Berliner, J. A. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m107602200 · Cited by 183
Obinata, H., Hattori, T., Nakane, S., Tatei, K., & Izumi, T. (2005) · Journal of Biological Chemistry · doi:10.1074/jbc.m507787200 · Cited by 183
Specific Phospholipid Oxidation Products Inhibit Ligand Activation of Toll-Like Receptors 4 and 2
Walton, K. A., Cole, A. L., Yeh, M., Subbanagounder, G., Krutzik, S. R., Modlin, R. L., Lucas, R. M., Nakai, J., Smart, E. J., Vora, D. K., et al. (2003) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/01.atv.0000079340.80744.b8 · Cited by 182
Jiang, Y., Oliver, P. L., Davies, K. E., & Platt, N. (2006) · Journal of Biological Chemistry · doi:10.1074/jbc.m507599200 · Cited by 181
Brown, A. J., Dean, R. T., & Jessup, W. (1996) · Journal of Lipid Research · doi:10.1016/s0022-2275(20)37619-7 · Cited by 181
Li, H., Freeman, M. W., & Libby, P. (1995) · Journal of Clinical Investigation · doi:10.1172/jci117628 · Cited by 179
Holvoet, P., Donck, J., Landeloos, M., Brouwers, E., Luijtens, K., Arnout, J., Lesaffre, E., Vanrenterghem, Y., & Collen, D. (1996) · Thrombosis and Haemostasis · doi:10.1055/s-0038-1650639 · Cited by 178
Su, J., Georgiades, A., Wu, R., Thulin, T., de Faire, U., & Frostegård, J. (2006) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2005.10.017 · Cited by 177
Wong, M., Xie, B., Beatini, N., Phu, P., Marathe, S. V., Johns, A., Gold, P. W., Hirsch, E., Williams, K. J., Licinio, J., et al. (2000) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.150098097 · Cited by 177
Ceruloplasmin and cardiovascular disease
Fox, P. L., Mazumder, B., Ehrenwald, E., & Mukhopadhyay, C. K. (2000) · Free Radical Biology and Medicine · doi:10.1016/s0891-5849(00)00231-8 · Cited by 177
Febbraio, M., Guy, E., & Silverstein, R. L. (2004) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/01.atv.0000148007.06370.68 · Cited by 177
Oxidized Phospholipids as Endogenous Pattern Recognition Ligands in Innate Immunity
Hazen, S. L. (2008) · Journal of Biological Chemistry · doi:10.1074/jbc.r700054200 · Cited by 176
Hiltunen, T. P., Luoma, J. S., Nikkari, T., & Ylä‐Herttuala, S. (1998) · Circulation · doi:10.1161/01.cir.97.11.1079 · Cited by 173
Huszar, D., Varban, M. L., Rinninger, F., Feeley, R., Arai, T., Fairchild-Huntress, V., Donovan, M. J., & Tall, A. R. (2000) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/01.atv.20.4.1068 · Cited by 173
Parthasarathy, S., Fong, L. G., Otero, D., et al. (1987) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.84.2.537 · Cited by 171
LDL- is a lipid hydroperoxide-enriched circulating lipoprotein
Sevanian, A., Bittolo-Bon, G., Cazzolato, G., Hodis, H., Hwang, J., Zamburlini, A., Maiorino, M., & Ursini, F. (1997) · Journal of Lipid Research · doi:10.1016/s0022-2275(20)37250-3 · Cited by 171
Puglielli, L., Rigotti, A., Greco, A. V., Santos, M. J., & Nervi, F. (1995) · Journal of Biological Chemistry · doi:10.1074/jbc.270.32.18723 · Cited by 168
The two faces of the 15-lipoxygenase in atherosclerosis
Wittwer, J., & Hersberger, M. (2007) · Prostaglandins, Leukotrienes and Essential Fatty Acids · doi:10.1016/j.plefa.2007.08.001 · Cited by 168
4-Hydroxynonenal and cholesterol oxidation products in atherosclerosis
Leonarduzzi, G., Chiarpotto, E., Biasi, F., & Poli, G. (2005) · Molecular Nutrition & Food Research · doi:10.1002/mnfr.200500090 · Cited by 168
Macrophage Foam Cell Formation with Native Low Density Lipoprotein
Kruth, H. S., Huang, W., Ishii, I., & Zhang, W.-Y. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m205059200 · Cited by 167
Hsieh, C. (2001) · Cardiovascular Research · doi:10.1016/s0008-6363(00)00218-2 · Cited by 166
Rheumatoid Arthritis A Model of Systemic Inflammation Driving Atherosclerosis
Ku, I. A., Imboden, J. B., Hsue, P. Y., & Ganz, P. (2009) · Circulation Journal · doi:10.1253/circj.cj-09-0274 · Cited by 164
Morrow, J. (2006) · Current Pharmaceutical Design · doi:10.2174/138161206776055985 · Cited by 162
The many faces of PPARγ: Anti-inflammatory by any means?
Szántó, A., & Nagy, L. (2008) · Immunobiology · doi:10.1016/j.imbio.2008.07.015 · Cited by 162
Babaev, V. R., Gleaves, L. A., Carter, K. J., Suzuki, H., Kodama, T., Fazio, S., & Linton, M. F. (2000) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/01.atv.20.12.2593 · Cited by 162
Kakutani, M., Masaki, T., & Sawamura, T. (2000) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.97.1.360 · Cited by 161
Endothelial nitric oxide synthase, caveolae and the development of atherosclerosis
Shaul, P. W. (2003) · The Journal of Physiology · doi:10.1113/jphysiol.2002.031534 · Cited by 159
Augè, N., Nikolova‐Karakashian, M., Carpentier, S., Parthasarathy, S., Nègre‐Salvayre, A., Salvayre, R., Merrill, A. H., & Levade, T. (1999) · Journal of Biological Chemistry · doi:10.1074/jbc.274.31.21533 · Cited by 157
Pitas, R. E. (1990) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(19)38404-2 · Cited by 156
Leitinger, N., Watson, A. D., Hama, S. Y., Ivandic, B., Qiao, J.-H., Huber, J., Faull, K. F., Grass, D., Navab, M., Fogelman, A. M., et al. (1999) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/01.atv.19.5.1291 · Cited by 154
Wu, B. J., Kathir, K., Witting, P. K., Beck, K., Choy, K. J., Li, C., Croft, K. D., Mori, T. A., Tanous, D. J., Adams, M. R., et al. (2006) · The Journal of Experimental Medicine · doi:10.1084/jem.20052321 · Cited by 153
Lordan, S., Mackrill, J. J., & O’Brien, N. M. (2009) · The Journal of Nutritional Biochemistry · doi:10.1016/j.jnutbio.2009.01.001 · Cited by 151
Dual Role of Oxidized LDL on the NF-KappaB Signaling Pathway
Robbesyn, F., Salvayre, R., & Nègre‐Salvayre, A. (2004) · Free Radical Research · doi:10.1080/10715760410001665244 · Cited by 148
Oxidized low density lipoprotein is resistant to cathepsins and accumulates within macrophages
Lougheed, M., Zhang, H. F., & Steinbrecher, U. P. (1991) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)98717-x · Cited by 147
Role of macrophage scavenger receptors in diet-induced atherosclerosis in mice.
Sakaguchi, H., Takeya, M., Suzuki, H., Hakamata, H., Kodama, T., Horiuchi, S., Gordon, S., van der Laan, L. J. W., Kraal, G., Ishibashi, S., et al. (1998) · PubMed · Cited by 146
Oxidative Modification of LDL: Its Pathological Role in Atherosclerosis
Itabe, H. (2008) · Clinical Reviews in Allergy & Immunology · doi:10.1007/s12016-008-8095-9 · Cited by 145
Upston, J. M., Niu, X., Brown, A. J., Mashima, R., Wang, H., Senthilmohan, R., Kettle, A. J., Dean, R. T., & Stocker, R. (2002) · American Journal Of Pathology · doi:10.1016/s0002-9440(10)64890-0 · Cited by 144
Autoimmunity in atherosclerosis: a protective response losing control?
Nilsson, J. Å., & Hansson, G. K. (2008) · Journal of Internal Medicine · doi:10.1111/j.1365-2796.2008.01945.x · Cited by 143
Naito, M., Suzuki, H., Mori, T., Matsumoto, A., Kodama, T., & Takahashi, K. I. (1992) · PubMed · Cited by 141
Dixon, W. G., & Symmons, D. P. M. (2007) · Annals of the Rheumatic Diseases · doi:10.1136/ard.2006.063867 · Cited by 140
Augè, N., Garcia, V., Maupas‐Schwalm, F., Levade, T., Salvayre, R., & Nègre‐Salvayre, A. (2002) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/01.atv.0000043453.21629.3b · Cited by 139
12/15-Lipoxygenase, Oxidative Modification of LDL and Atherogenesis
Cyrus, C. (2001) · Trends in Cardiovascular Medicine · doi:10.1016/s1050-1738(01)00096-2 · Cited by 139
Electronegative low-density lipoprotein
Sánchez‐Quesada, J. L., tez, S. B., & Ordóñez‐Llanos, J. (2004) · Current Opinion in Lipidology · doi:10.1097/00041433-200406000-00014 · Cited by 138
Lu, J., Yang, J.-H., Burns, A. R., Chen, H.-H., Tang, D., Walterscheid, J. P., Suzuki, S., Yang, C.-Y., Sawamura, T., & Chen, C.-H. (2009) · Circulation Research · doi:10.1161/circresaha.108.190116 · Cited by 137 · cited 2×
“(2009) showed that both L5 and OxLDL (generated by Cu2þoxidaxidation of LDL) induced LOX-1 in endothelial cells and competed for uptake by this receptor (175).”
Analysis of Macrophage Scavenger Receptor (SR-A) Expression in Human Aortic Atherosclerotic Lesions
Gough, P. J., Greaves, D. R., Suzuki, H., Häkkinen, T., Hiltunen, M. O., Turunen, M. P., Ylä‐Herttuala, S., Kodama, T., & Gordon, S. (1999) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/01.atv.19.3.461 · Cited by 136
Natural antibodies and the autoimmunity of atherosclerosis
Binder, C. J., & Silverman, G. J. (2004) · Springer Seminars in Immunopathology · doi:10.1007/s00281-004-0185-z · Cited by 136
Alternative forms of the scavenger receptor BI (SR-BI)
Webb, N. R., de Villiers, W. J. S., Connell, P. M., de Beer, F. C., & van der Westhuyzen, D. R. (1997) · Journal of Lipid Research · doi:10.1016/s0022-2275(20)37431-9 · Cited by 132
Oxidized amino acids: culprits in human atherosclerosis and indicators of oxidative stress
Heinecke, J. W. (2002) · Free Radical Biology and Medicine · doi:10.1016/s0891-5849(02)00792-x · Cited by 126
Lougheed, M., Lum, C. M., Ling, W., Suzuki, H. I., Kodama, T., & Steinbrecher, U. P. (1997) · Journal of Biological Chemistry · doi:10.1074/jbc.272.20.12938 · Cited by 124
The interaction of macrophage receptors with bacterial ligands
Plüddemann, A., Mukhopadhyay, S., & Gordon, S. (2006) · Expert Reviews in Molecular Medicine · doi:10.1017/s1462399406000159 · Cited by 124
Gough, P. J., Greaves, D. R., & Gordon, S. (1998) · Journal of Lipid Research · doi:10.1016/s0022-2275(20)33292-2 · Cited by 123
The intracellular storage and turnover of apolipoprotein B of oxidized LDL in macrophages
Jessup, W., Mander, E. L., & Dean, R. T. (1992) · Biochimica et Biophysica Acta (BBA) - Lipids and Lipid Metabolism · doi:10.1016/0005-2760(92)90287-6 · Cited by 122
Saad, A. F., Virella, G., Chassereau, C. N., Boackle, R. J., & Lopes-Virella, M. F. (2006) · Journal of Lipid Research · doi:10.1194/jlr.m600064-jlr200 · Cited by 122
Is oxidized low‐density lipoprotein present in vivo?
Ylä‐Herttuala, S. (1998) · Current Opinion in Lipidology · doi:10.1097/00041433-199808000-00009 · Cited by 121
Lipoprotein Cholesterol and Atherosclerosis
Kruth, H. S. (2001) · Current Molecular Medicine · doi:10.2174/1566524013363212 · Cited by 121
Verhoye, E., & Langlois, M. R. (2008) · Clinical Chemistry and Laboratory Medicine (CCLM) · doi:10.1515/cclm.2009.037 · Cited by 120
Winyard, P., Tatzber, F., Esterbauer, H., Kus, M. L., Blake, D., & Morris, C. (1993) · Annals of the Rheumatic Diseases · doi:10.1136/ard.52.9.677 · Cited by 118
Nakamura, K. D., Funakoshi, H., Miyamoto, K., Tokunaga, F., & Nakamura, T. (2001) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.2000.4210 · Cited by 116
Characterization of endothelial cell injury by cholesterol oxidation products found in oxidized LDL.
Sevanian, A., Hodis, H. N., Hwang, J., McLeod, L. L., & Peterson, H. (1995) · Journal of Lipid Research · doi:10.1016/s0022-2275(20)41115-0 · Cited by 114
Identification of Prostaglandin E2 Receptor Subtype 2 As a Receptor Activated by OxPAPC
Li, R., Mouillesseaux, K. P., Montoya, D. J., Cruz, D., Gharavi, N., Dun, M., Koroniak, Ł., & Berliner, J. A. (2006) · Circulation Research · doi:10.1161/01.res.0000207394.39249.fc · Cited by 113
The uptake of LDL-IC by human macrophages: predominant involvement of the FcγRI receptor
Lopes-Virella, M. F., Binzafar, N., Rackley, S., Takei, A., Via, M. L., & Virella, G. (1997) · Atherosclerosis · doi:10.1016/s0021-9150(97)00157-3 · Cited by 112
Thrombogenic and atherogenic activities of lysophosphatidic acid
Siess, W., & Tigyi, G. (2004) · Journal of Cellular Biochemistry · doi:10.1002/jcb.20108 · Cited by 112
Brown, A. J., Mander, E. L., Gelissen, I. C., Kritharides, L., Dean, R. T., & Jessup, W. (2000) · Journal of Lipid Research · doi:10.1016/s0022-2275(20)32056-3 · Cited by 112
Oxidized LDL Contains Inflammatory PAF-Like Phospholipids
Marathe, G. K., Prescott, S. M., Zimmerman, G. A., & McIntyre, T. M. (2001) · Trends in Cardiovascular Medicine · doi:10.1016/s1050-1738(01)00100-1 · Cited by 110
Oxidative Biomarkers in the Diagnosis and Prognosis of Cardiovascular Disease
Tsimikas, S. (2006) · The American Journal of Cardiology · doi:10.1016/j.amjcard.2006.09.015 · Cited by 110
Shaw, P. X., Goodyear, C. S., Chang, M.-K., Witztum, J. L., & Silverman, G. J. (2003) · The Journal of Immunology · doi:10.4049/jimmunol.170.12.6151 · Cited by 110
Paradoxical actions of antioxidants in the oxidation of low density lipoprotein by peroxidases.
Santanam, N., & Parthasarathy, S. (1995) · Journal of Clinical Investigation · doi:10.1172/jci117961 · Cited by 109
Li, S., Ishida, T., Yasuda, T., Kojima, Y., Honjo, T., Yamamoto, Y., Yamamoto, H., Ishibashi, S., Hirata, K., & Hayashi, Y. (2008) · Cardiovascular Research · doi:10.1093/cvr/cvp036 · Cited by 109
Valiyaveettil, M., Kar, N. S., Ashraf, M. Z., Byzova, T. V., Febbraio, M., & Podrez, E. A. (2007) · Blood · doi:10.1182/blood-2007-08-107813 · Cited by 108
Harkewicz, R., Hartvigsen, K., Almazan, F., Dennis, E. A., Witztum, J. L., & Miller, Y. I. (2008) · Journal of Biological Chemistry · doi:10.1074/jbc.m709006200 · Cited by 108
Zhang, H., Yang, Y., & Steinbrecher, U. P. (1993) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)53354-8 · Cited by 106
Low Density Lipoprotein Undergoes Oxidation Within Lysosomes in Cells
Wen, Y., & Leake, D. S. (2007) · Circulation Research · doi:10.1161/circresaha.107.151704 · Cited by 103
Yeh, M. W., Cole, A. L., Choi, J., Liu, Y., Tulchinsky, D., Qiao, J.-H., Fishbein, M. C., Dooley, A. N., Hovnanian, T., Mouillesseaux, K. P., et al. (2004) · Circulation Research · doi:10.1161/01.res.0000146030.53089.18 · Cited by 102
Bioactive products of phospholipid oxidation: isolation, identification, measurement and activities
Subbanagounder, G., Watson, A. D., & Berliner, J. A. (2000) · Free Radical Biology and Medicine · doi:10.1016/s0891-5849(00)00233-1 · Cited by 100
Activation of transcription factors and gene expression by oxidized low-density lipoprotein
Mazière, C., & Mazière, J. (2008) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2008.10.024 · Cited by 100
Atherosclerosis and Oxidant Stress: The End of the Road for Antioxidant Vitamin Treatment?
Thomson, M. J. C. B., Püntmann, V. O., & Kaski, J. C. (2007) · Cardiovascular Drugs and Therapy · doi:10.1007/s10557-007-6027-1 · Cited by 100
de Winther, M. P. J., Gijbels, M. J., van Dijk, K. W., van Gorp, P. J., Suzuki, H., Kodama, T., Frants, R. R., Havekes, L. M., & Hofker, M. H. (1999) · Atherosclerosis · doi:10.1016/s0021-9150(98)00332-3 · Cited by 98
Association of ceramides in human plasma with risk factors of atherosclerosis
Ichi, I., Nakahara, K., Miyashita, Y., Hidaka, A., Kutsukake, S., Inoue, K., Maruyama, T., Miwa, Y., Harada‐Shiba, M., Tsushima, M., et al. (2006) · Lipids · doi:10.1007/s11745-006-5041-6 · Cited by 96
Autoimmune response to advanced glycosylation end-products of human LDL
Virella, G., Thorpe, S. R., Alderson, N. L., Stephan, E. M., Atchley, D. H., Wagner, F., & Lopes-Virella, M. F. (2003) · Journal of Lipid Research · doi:10.1194/jlr.m200370-jlr200 · Cited by 93
NICHOLSON, A. C. (2004) · Trends in Cardiovascular Medicine · doi:10.1016/j.tcm.2003.09.004 · Cited by 93
Murphy, J. E., Tacon, D., Tedbury, P. R., Hadden, J. M., Knowling, S., Sawamura, T., Peckham, M., Phillips, S. E. V., Walker, J. H., & Ponnambalam, S. (2005) · Biochemical Journal · doi:10.1042/bj20051166 · Cited by 92
Kato, R., Mori, C., Kitazato, K. T., Arata, S., Obama, T., Mori, M., Takahashi, K., Aiuchi, T., Takano, T., & Itabe, H. (2008) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/atvbaha.108.164723 · Cited by 91
Cited by
Pathophysiology of Atherosclerosis
Jebari-Benslaiman, S., Galicia-García, U., Larrea-Sebal, A., Olaetxea, J. R., Alloza, I., Vandenbroeck, K., Benito-Vicente, A., & Martín, C. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23063346 · Cited by 1,010
Lippert, A. R., Van de Bittner, G. C., & Chang, C. J. (2011) · Accounts of Chemical Research · doi:10.1021/ar200126t · Cited by 798
LOX-1, OxLDL, and Atherosclerosis
Pirillo, A., Norata, G. D., & Catapano, A. L. (2013) · Mediators of Inflammation · doi:10.1155/2013/152786 · Cited by 769
HDL and cardiovascular disease: atherogenic and atheroprotective mechanisms
Navab, M., Reddy, S. T., Van Lenten, B. J., & Fogelman, A. M. (2011) · Nature Reviews Cardiology · doi:10.1038/nrcardio.2010.222 · Cited by 656
Metabolic syndrome and cardiovascular diseases: Going beyond traditional risk factors
Silveira Rossi, J. L., Barbalho, S. M., Reverete de Araujo, R., Bechara, M. D., Sloan, K. P., & Sloan, L. A. (2022) · Diabetes/Metabolism Research and Reviews · doi:10.1002/dmrr.3502 · Cited by 604
Metadata
- Authors
- Levitan, I., Volkov, S., & Subbaiah, P. V.
- Venue
- Antioxidants & Redox Signaling
- Publisher
- SAGE Publications
- Published
- 2010-07
- Volume
- 13
- Issue
- 1
- Pages
- 39-75
- ISSN
- 1523-0864 (ISSN-L)
- 1557-7716
- OpenAlex
- W2049746695
- Cited by
- 473
- References
- 295
- FWCI
- 6.24
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.